Related Experiment Video
Updated: Mar 17, 2026

In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
Genomic approaches to diagnose rare bone disorders
Félix Falardeau1, Maria Vittoria Camurri2, Philippe M Campeau3
1CHU Sainte-Justine Research Center, Montreal, Canada; Division of Molecular and Cellular Biology, Department of Biology, University of Sherbrooke, Sherbrooke, Canada.
Diagnosing skeletal dysplasias, rare Mendelian disorders, can be complex due to genetic variability. This review explores various sequencing techniques, including next-generation sequencing, to achieve accurate molecular diagnoses.
Area of Science:
- Genetics
- Molecular Biology
- Medical Diagnostics
Background:
- Skeletal dysplasias are Mendelian disorders affecting approximately 1 in 5000 individuals.
- Clinical and radiological findings aid diagnosis, but genetic complexity poses challenges.
- Genetic heterogeneity means multiple genes can cause similar phenotypes, and single genes can lead to diverse conditions.
Purpose of the Study:
- To review different approaches for achieving molecular diagnoses in skeletal dysplasias.
- To describe the advantages and limitations of various sequencing technologies.
- To provide an overview of emerging technologies for future applications.
Main Methods:
- Review of single gene sequencing, next-generation sequencing (NGS) approaches.
- Detailed examination of first, second, and third-generation sequencing technologies.
- Inclusion of whole-exome sequencing (WES), whole-genome sequencing (WGS), and gene panel sequencing.
Main Results:
- Sequencing technologies offer diverse strategies for molecular diagnosis of skeletal dysplasias.
- Each sequencing generation presents unique advantages and limitations regarding cost, speed, and data output.
- Next-generation sequencing (NGS) provides comprehensive genomic insights.
Conclusions:
- Molecular diagnosis of skeletal dysplasias is facilitated by a range of advanced sequencing methods.
- Choosing the appropriate sequencing strategy is crucial for efficient and accurate diagnosis.
- Emerging technologies promise further advancements in diagnosing these complex genetic disorders.
More Related Videos
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
05:51A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Karyotyping